DIN 02523434 — JEMPERLI 50 MG
JEMPERLI is a solution of Dostarlimab marketed by GLAXOSMITHKLINE INC. The full Dostarlimab monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02523434
- Brand name
- JEMPERLI
- Active ingredient
- Dostarlimab
- Strength
- 50 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- GLAXOSMITHKLINE INC
- Health Canada status
- MARKETED
- Drug class
- Anti-PD-1 monoclonal antibody (immune checkpoint inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.